Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Lazard Asset Management LLC

Lazard Asset Management LLC lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 4.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,192,032 shares of the company’s stock after selling 114,108 shares during the quarter. Lazard Asset Management LLC owned approximately 1.76% of Henry Schein worth $151,688,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the business. Smartleaf Asset Management LLC raised its stake in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after purchasing an additional 143 shares during the period. Guggenheim Capital LLC increased its stake in Henry Schein by 2.5% during the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock valued at $445,000 after buying an additional 159 shares during the period. CIBC Asset Management Inc boosted its holdings in shares of Henry Schein by 1.0% in the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock valued at $1,235,000 after acquiring an additional 169 shares in the last quarter. Metis Global Partners LLC raised its holdings in Henry Schein by 4.7% during the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock worth $291,000 after purchasing an additional 187 shares in the last quarter. Finally, Sanctuary Advisors LLC increased its position in shares of Henry Schein by 5.0% during the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock valued at $294,000 after purchasing an additional 203 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HSIC has been the subject of a number of research reports. Barrington Research reduced their target price on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating for the company in a report on Tuesday, May 6th. Wells Fargo & Company dropped their target price on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 6th. Piper Sandler reduced their price target on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research report on Wednesday, April 30th. UBS Group lowered their price objective on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Finally, Jefferies Financial Group raised their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $79.30.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the firm’s stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares of the company’s stock, valued at approximately $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now directly owns 24,805 shares in the company, valued at $1,762,147.20. This trade represents a 9.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is currently owned by corporate insiders.

Henry Schein Price Performance

Shares of HSIC opened at $68.68 on Monday. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a market cap of $8.41 billion, a price-to-earnings ratio of 28.26, a PEG ratio of 2.13 and a beta of 0.87. The company’s fifty day simple moving average is $67.59 and its 200 day simple moving average is $71.46. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the business earned $1.10 earnings per share. The company’s revenue was down .1% on a year-over-year basis. On average, research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.